HR
AMAG

Howe & Rusling’s AMAG Pharmaceuticals AMAG Stock Holding History

Howe & Rusling’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-78
Closed – – 950
2020
Q1 		$0 Sell
78
-6
-7% -$53 ﹤0.01% 924
2019
Q4 		$1K Hold
84
– – ﹤0.01% 820
2019
Q3 		$1K Hold
84
– – ﹤0.01% 823
2019
Q2 		$1K Buy
84
+1
+1% +$11 ﹤0.01% 795
2019
Q1 		$1K Sell
83
-12
-13% -$179 ﹤0.01% 793
2018
Q4 		$1K Buy
95
+28
+42% +$534 ﹤0.01% 796
2018
Q3 		$1K Hold
67
– – ﹤0.01% 844
2018
Q2 		$1K Sell
67
-135
-67% -$2.99K ﹤0.01% 802
2018
Q1 		$4K Buy
202
+39
+24% +$660 ﹤0.01% 664
2017
Q4 		$2K Hold
163
– – ﹤0.01% 752
2017
Q3 		$3K Hold
163
– – ﹤0.01% 707
2017
Q2 		$3K Hold
163
– – ﹤0.01% 768
2017
Q1 		$4K Sell
163
-21
-11% -$503 ﹤0.01% 727
2016
Q4 		$6K Hold
184
– – ﹤0.01% 649
2016
Q3 		$5K Buy
184
+90
+96% +$2.25K ﹤0.01% 690
2016
Q2 		$2K Buy
94
+10
+12% +$229 ﹤0.01% 868
2016
Q1 		$2K Buy
84
+25
+42% +$593 ﹤0.01% 895
2015
Q4 		$2K Buy
+59
New +$1.91K ﹤0.01% 869

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Howe & Rusling's AMAG Position: Q2 2020 in Review

Howe & Rusling sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 78 shares.

Howe & Rusling first reported a position in AMAG in Q4 2015 and held it in 18 quarters. The position peaked at $6K in Q4 2016. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

  • Howe & Rusling reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Howe & Rusling sold 78 AMAG Pharmaceuticals shares in Q2 2020.
  • Howe & Rusling first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 18 quarters.
  • Howe & Rusling's AMAG Pharmaceuticals position peaked at $6K in Q4 2016.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on Howe & Rusling's 13F filing for Q2 2020, filed 15 Jul 2020.